The New Jersey Medical Marijuana Review Panel has issued initial recommendations to add several new qualifying conditions to the state’s medical marijuana program: chronic pain related to musculoskeletal disorders or of visceral origin, migraine, anxiety, and Tourette’s Syndrome. There will now be a 60-day public comment period, after which the Panel will consider the comments and hold another meeting before making its final recommendations. If you are a New Jersey resident suffering from one of…